Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,229,681,638
+$174,079,352 QoQ
Shares Held
4,886,670
+0.7% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#39
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. ABBV ranks #3 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
|
9,513,242 | $229,078,867 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,229,681,638 | 4,886,670 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,055,602,286 | 4,853,567 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,103,201,358 | 4,828,226 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,226,873,038 | 5,298,752 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $998,135,725 | 5,377,307 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,060,080,687 | 5,059,568 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $882,069,392 | 4,963,812 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $983,179,852 | 4,978,630 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $866,450,088 | 5,051,598 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $850,357,286 | 4,669,727 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $708,209,955 | 4,569,981 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $655,462,879 | 4,397,309 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $440,118,583 | 3,266,671 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $538,952,684 | 3,381,770 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $552,609,234 | 3,419,400 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $457,849,630 | 3,411,442 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $507,222,728 | 3,311,718 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $539,236,705 | 3,326,363 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $431,376,140 | 3,185,939 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $337,716,267 | 3,130,771 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $333,181,235 | 2,957,930 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $311,581,613 | 2,879,150 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $246,442,214 | 2,299,974 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $198,568,106 | 2,267,018 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $222,878,908 | 2,270,105 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $161,629,770 | 2,121,404 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||